Kolon Pharmaceutical, Inc. was established in 1958 with a mission to contribute on happiness of mankind and social welfare by enhancing people’s quality of life and providing top medical service thru development of innovative drugs with its respect for life and health. Kolon Pharmaceutical is a subsidiary of Kolon group which is one of the biggest industrial conglomerates of Korea that has core business domains in pharmaceuticals, biotechnology, cutting-edge materials, fashion, construction, environment, trade and IT. Kolon group’s health business unit is composed of three subsidiaries and they are Kolon Pharmaceuticals, Kolon Life Science(biotechnology) and Kolon Wellcare(drug store business). Kolon Pharmaceutical developed many outstanding products like Bicogreen for constipation, cold remedy Comy syrup & tablet, anti-fungal drug Konitra and Tamsulo capsule for prostatism with its own technology and also co-developed Brexin tablet(β-Cyclodextrin Prioxicam), Remicut SR capsule(Emedastine difumarate) and Pransus syrup(Pranoprofen) with outstanding pharmaceutical companies like Chiesi, Hisamitsu and Organon since its establishment. Kolon Pharmaceutical is also expanding its global presence by exporting its quality products like Flavon(Ginko biloba ext.), Diverine(Gliclazide), Tavisin(Ofloxacin), Clovana(Diclofenac) and Turant(Acetylcysteine) to Vietnam, Pakistan, Yemen and many other Middle Eastern countries. Our continuous efforts led us to fruitful outcomes in significant areas of our business especially new molecule research, joint research, development of API, new formulation and combination new drug.
View Top Employees from Kolon Pharmaceutical, Inc.Website | http://www.kolonpharm.co.kr |
Revenue | $5 million |
Employees | 111 (54 on RocketReach) |
Founded | 1958 |
Address | Tower Annex 13 Kolon-ro Kolon Fl 6, Gwacheon, Gyeonggi-do, KR |
Phone | +82 42-930-5710 |
Technologies |
JavaScript,
PHP,
Twitter
+4 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
Web Rank | 3 Million |
Keywords | Pharmaceutical Research, Biotechnology, Drug Development And Manufacturing, Healthcare, Pharmaceutical Products, Generic Drugs, Api Manufacturer, Pharmaceutical Formulation, Pharmaceutical Export |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Kolon Pharmaceutical, Inc. employee's phone or email?
The Kolon Pharmaceutical, Inc. annual revenue was $5 million in 2024.
Paul Kim is the Director of Administration and Finance, Chief Financial Officer of Kolon Pharmaceutical, Inc..
54 people are employed at Kolon Pharmaceutical, Inc..
Kolon Pharmaceutical, Inc. is based in Gwacheon, Gyeonggi-do.
The NAICS codes for Kolon Pharmaceutical, Inc. are [325, 32541, 3254, 32].
The SIC codes for Kolon Pharmaceutical, Inc. are [28, 283].